These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 19887580)
1. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice. Kim J; Xing W; Wergedal J; Chan JY; Mohan S Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency. Mohan S; Kapoor A; Singgih A; Zhang Z; Taylor T; Yu H; Chadwick RB; Chung YS; Donahue LR; Rosen C; Crawford GC; Wergedal J; Baylink DJ J Bone Miner Res; 2005 Sep; 20(9):1597-610. PubMed ID: 16059632 [TBL] [Abstract][Full Text] [Related]
3. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss. Wang L; Liu S; Quarles LD; Spurney RF Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587 [TBL] [Abstract][Full Text] [Related]
4. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass. Nakanishi R; Akiyama H; Kimura H; Otsuki B; Shimizu M; Tsuboyama T; Nakamura T J Bone Miner Res; 2008 Feb; 23(2):271-7. PubMed ID: 17907918 [TBL] [Abstract][Full Text] [Related]
5. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029 [TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular effects of growth hormone and estrogen on human bone cells. Kassem M APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492 [TBL] [Abstract][Full Text] [Related]
7. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro. Zhang W; Pantschenko AG; McCarthy MB; Gronowicz G Calcif Tissue Int; 2007 Feb; 80(2):111-22. PubMed ID: 17308993 [TBL] [Abstract][Full Text] [Related]
8. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice. Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141 [TBL] [Abstract][Full Text] [Related]
9. The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice. Schinke T; Gebauer M; Schilling AF; Lamprianou S; Priemel M; Mueldner C; Neunaber C; Streichert T; Ignatius A; Harroch S; Amling M Bone; 2008 Mar; 42(3):524-34. PubMed ID: 18178537 [TBL] [Abstract][Full Text] [Related]
10. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice. Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162 [TBL] [Abstract][Full Text] [Related]
11. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606 [TBL] [Abstract][Full Text] [Related]
12. Osteoblastic molecular scaffold Gab1 is required for maintaining bone homeostasis. Weng T; Mao F; Wang Y; Sun Q; Li R; Yang G; Zhang X; Luo J; Feng GS; Yang X J Cell Sci; 2010 Mar; 123(Pt 5):682-9. PubMed ID: 20124419 [TBL] [Abstract][Full Text] [Related]
13. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. Kalajzic I; Kalajzic Z; Kaliterna M; Gronowicz G; Clark SH; Lichtler AC; Rowe D J Bone Miner Res; 2002 Jan; 17(1):15-25. PubMed ID: 11771662 [TBL] [Abstract][Full Text] [Related]
14. Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice. Sobue T; Naganawa T; Xiao L; Okada Y; Tanaka Y; Ito M; Okimoto N; Nakamura T; Coffin JD; Hurley MM J Cell Biochem; 2005 May; 95(1):83-94. PubMed ID: 15723277 [TBL] [Abstract][Full Text] [Related]
15. Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength. Wezeman FH; Emanuele MA; Emanuele NV; Moskal SF; Woods M; Suri M; Steiner J; LaPaglia N Alcohol Clin Exp Res; 1999 Sep; 23(9):1534-42. PubMed ID: 10512321 [TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. Okamoto M; Murai J; Yoshikawa H; Tsumaki N J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523 [TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice. Kadowaki A; Tsukazaki T; Hirata K; Shibata Y; Okubo Y; Bessho K; Komori T; Yoshida N; Yamaguchi A Bone; 2004 Jun; 34(6):993-1003. PubMed ID: 15193545 [TBL] [Abstract][Full Text] [Related]
18. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481 [TBL] [Abstract][Full Text] [Related]
19. TGFbeta inducible early gene-1 knockout mice display defects in bone strength and microarchitecture. Bensamoun SF; Hawse JR; Subramaniam M; Ilharreborde B; Bassillais A; Benhamou CL; Fraser DG; Oursler MJ; Amadio PC; An KN; Spelsberg TC Bone; 2006 Dec; 39(6):1244-51. PubMed ID: 16876494 [TBL] [Abstract][Full Text] [Related]